Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 18/20 | 0.69 |
| ▸ | TACR2 | P21452 | 8/20 | 0.69 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | TACR1 | P25103 | 1/20 | 0.69 |
| ▸ | DHODH | Q02127 | 2/20 | 0.56 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7692677 | 1.00 | TACR3 (0.69) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL4466777 | 0.88 | TACR3 (0.69) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL4466774 | 0.88 | TACR3 (0.69) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL8800338 | 0.86 | TACR3 (0.74) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL3584610 | 0.83 | TACR3 (0.72) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL7690429 | 0.82 | TACR3 (0.70) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| SCHEMBL7690427 | 0.82 | TACR3 (0.70) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| Talnetant SCHEMBL74220 | 0.81 | TACR3 (1.00) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| Talnetant SCHEMBL6449764 | 0.81 | TACR3 (1.00) | TACR3TACR2OPRM1CYP1A2CYP3A4 | |
| Talnetant SCHEMBL29604291 | 0.81 | TACR3 (1.00) | TACR3TACR2OPRM1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020068827-A1 | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists | SMITHKLINE BEECHAM S.P.A. | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068827-A1 | Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists | TAC3, TACR2, TACR1 | TACR3 40/4885TACR2 2/4885OPRM1 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.